VENTRICULAR SEPTAL DEFECT -VSD

 

VENTRICULAR SEPTAL DEFECT

 

DEFINITION:

An acyanotic congenital heart disease characterized by defects in the ventricular septum.

EPIDEMIOLOGY:

  • incidence: 25-30% of all congenital cardiac lesions
  • age of first detection:
    • newborn - 2 days (small VSD) to >1 week (large VSD)
  • risk factors:
    • certain chromosomal and genetic disorders and syndromes

TYPES (4):

1. Type 1 - 15%

  • defect occurs between the crista supraventricularis and pulmonary valve
  • may be associated with pulmonary stenosis

2. Type 2 (Perimembranous) - 60-80%

  • defect occurs within the membranous septum

3. Type 3

  • defect occurs superior to the crista supraventricularis
  • defect occurs in the inlet portion of the right ventricle beneath the septal leaflet of the tricuspid valve
  • may impinge on an aortic sinus causing aortic insufficiency

4. Type 4 (Muscular)

  • defect occurs in the muscular septum
  • may be single or multiple (Swiss-cheese type)

ASSOCIATED ANOMALIES:

  • ASD
  • Pulmonary Stenosis
  • Tricuspid Atresia
  • TGA
  • Patent Ductus Arteriosus
  • Coarctation of the Aorta

PATHOPHYSIOLOGY:

1. Small Defects (Restrictive)

  • less than ½ the surface area of the aortic root
  • pulmonary to systemic flow ratio <1.75:1
  • insignificant L->R shunt
    • normal cardiac chambers and pulmonary vascular bed

2. Large Defects (Unrestrictive)

  • greater than the surface area of the aortic root
  • pulmonary to systemic flow ratio >3:1
  • usually appears several weeks after birth due to the natural fall in pulmonary vascular resistence as the muscular media of the small pulmonary arteries and arterioles involutes
  • degree of L->R shunt is determined by:
    • size of defect
    • ratio of pulmonary to systemic vascular resistence
  • significant L->R shunt produces:
    • RV and pulmonary artery hypertension
    • enlarged pulmonary artery trunk and left atrium
    • left ventricular (LV) volume overload and LV enlargement

CLINICAL FEATURES:

1. Symptoms

1. Asymptomatic

  • small defects with trivial L->R shunt
  • usually found on routine physical examination

2. Symptomatic

  • large defects with significant pulmonary hypertension
    • CHF
    • dyspnea
    • failure to thrive
    • feeding difficulties
    • profuse perspiration
    • recurrent lung infections

2. Signs

1. Periphery

  • normal

2. Palpation

  • thrill @ LLSB (VSD murmer)
  • parasternal lift (RVH) and apical thrust (LVH)

3. Auscultation

1. Heart Sounds

1. S1 - normal

2. S2 - loud

  • initially widely split due to prolonged RV ejection time due to increased RV blood volume
  • later single as pulmonary pressure approaches systemic pressure

2. Murmurs

1. Systolic

1. VSD
  • loud (grade 3/6), harsh, blowing (high-pitched) pansystolic murmur @ L 3rd and 4th interspaces

2. Diastolic

1. Relative Mitral Valve Stenosis
  • short mid-diastolic murmur @ apex
  • increased blood flow across the mitral valve
2. Aortic Insufficiency
  • in 5% of VSD's
  • diastolic murmur @ mLSB

3. Complications

1. Infectious

  • subacute bacterial endocarditis (SBE)
  • recurrent respiratory infections

2. Structural Defects

1. Infundibular Pulmonary Stenosis

  • produces a two-chambered RV with mid cavity obstruction
  • protects pulmonary circulation from long term pulmonary hypertension
  • may eventually produce a R->L shunt and cyanosis
  • presents after 1 year of age

2. Aortic Valve Insufficiency

  • aortic valve prolapse
  • formation of a subaortic shelf (stenosis) with the perimembranous type of defect
  • presents after 1 year of age

3. Pulmonary Hypertension (PH)

1. Dynamic PH - increased flow; decreased PVR - benign

2. Reactive PH - increased flow; normal PVR - @ 1 year of age

3. Fixed PH - decreased flow; increased PVR - > 1 year of age

4. Passive PH - decreased flow; normal PVR - due to TAPVR, pulmonary venous stenosis, elevated PVED, mitral valve stenosis

4. Congestive Heart Failure (CHF)

  • shortness of breath, exercise intolerance

INVESTIGATIONS:

1. Chest X-Ray

  • cardiomegaly with prominence of ventricles, LA, and PA
  • increased pulmonary vasculature

2. ECG

  • LVH -> biventricular hypertrophy -> RVH
  • LAH

3. 2D-Echo

  • VSD
  • volume overload of ventricles and LA
  • to follow for the development of a 2-chambered RV, subaortic stenosis, aortic valve prolapse

MANAGEMENT:

1. Supportive

  • VSD's are well tolerated during childhood and there is no need for restriction of activity

1. Medical Management

1. Antibiotic Prophylaxis

  • adenoidectomy
  • dental surgery
  • oropharyngeal surgical procedures
  • tonsillectomy
  • any instrumentation of the genitourinary and lower intestinal tracts

2. Congestive Heart Failure

  • digoxin and lasix

2. Surgery

1. Indications for:

1. Medical

  • unsuccessful medical control of complications
    • failure to thrive
    • recurrent lung infections
    • congestive heart failure, exercise intolerance
    • one episode of subacute bacterial endocarditis
    • new onset of mid diastolic murmur (aortic insufficiency)
    • pulmonary hypertension (new onset of loud narrow S2, RV heave, loss of thrill; ECG with RVH)

2. Echocardiogram

1. Pulmonary Hypertension
  • pulmonary to systemic flow ratio >3:1
  • SVR/PVR = 3:1 (a ratio of <3:1 suggests significant pulmonary hypertension and high surgical risk)

3. After 1 year of Age

  • mortality rate for direct repair is 42% if <1 year
  • usually do not refer to a cardiologist until 1 year
  • may band the pulmonary artery prior to 1 year of age then complete repair of the VSD at 3-4 years of age

2. Types

1. Pulmonary Artery Banding

  • indicated if repair needed prior to 1 year of age

2. Direct Repair

1. Primary Suture
  • for small VSD's
2. Dacron Patch
  • for larger VSD's

3. Post-Operative Complications

1. Hemorrhage

  • from chest wall or ventriculotomy
  • persistent drainage from chest tubes, cardiac tamponade, or hemothorax are indications for reoperation

2. Pulmonary Edema

  • after banding or direct repair if additional lesions present

3. Heart Block

  • due to injury to the conduction bundle

4. Heart Failure

  • with elevated CVP, low cardiac output, and hypotension
  • particularly in patients with pulmonary hypertension
  • may treat with isoproterenol or tolazoline to lower pulmonary resistance

5. Death

  • mortality rate for direct repair is about 7%
  • only in those with severe pulmonary hypertension

3. Prognosis

1. Small (Restrictive) VSD

  • 75-80% close spontaneously
    • 90% of muscular VSD's
    • 70% of perimembranous VSD's
  • 20-25% remain open
    • clinically insignificant
    • need prophylactic antibiotics for procedures

2. Large (Unrestrictive) VSD

  • all remain open and will eventually need to be surgically corrected after a period of medical management

 

 

 

Pediatric Database - VENTRICULAR SEPTAL DEFECT -VSD

Pediatric Organization - Pedbase [at] Gmail.com